Th9 and Th22 immune response in young patients with type 1 diabetes.
about
Changes of circulating Th22 cells in children with hand, foot, and mouth disease caused by enterovirus 71 infectionObstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
P2860
Th9 and Th22 immune response in young patients with type 1 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Th9 and Th22 immune response in young patients with type 1 diabetes.
@en
Th9 and Th22 immune response in young patients with type 1 diabetes.
@nl
type
label
Th9 and Th22 immune response in young patients with type 1 diabetes.
@en
Th9 and Th22 immune response in young patients with type 1 diabetes.
@nl
prefLabel
Th9 and Th22 immune response in young patients with type 1 diabetes.
@en
Th9 and Th22 immune response in young patients with type 1 diabetes.
@nl
P2860
P50
P1433
P1476
Th9 and Th22 immune response in young patients with type 1 diabetes.
@en
P2093
Jolanta Myśliwska
Paulina Werner
P2860
P2888
P304
P356
10.1007/S12026-015-8765-7
P577
2015-12-12T00:00:00Z